Ca(2+)/calmodulin-dependent protein kinase II is associated with pelvic pain of neurogenic cystitis.
Interstitial cystitis/painful bladder syndrome is a chronic bladder inflammatory disease of unknown etiology that is often regarded as a neurogenic cystitis. Interstitial cystitis is associated with urothelial lesions, voiding dysfunction, and pain in the pelvic/perineal area. In this study, we used a murine neurogenic cystitis model to identify genes participating in the development of pelvic pain. Neurogenic cystitis was induced by the injection of Bartha's strain of pseudorabies virus (PRV) into the abductor caudalis dorsalis (tail base) muscle of female C57BL/6J mice. Mice infected with PRV developed progressive pelvic pain. The sacral spinal cord was harvested on postinfection days (PID) 2 and 4, and gene expression was analyzed by microarrays and confirmed by quantitative RT-PCR. On PID 2, the overall expression profile was similar to that of uninfected sacral spinal cord; by PID 4, there were substantial differences in expression of multiple functional classes of genes, especially inflammation. Analysis of pain-signaling pathways at the dorsal horn suggested that Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to neurogenic cystitis pelvic pain. Consistent with this, CaMKIIδ expression exhibited a mast cell-dependent increase in the sacral spinal cord at the mRNA level, and phospho-CaMKII immunoreactivity in the dorsal horn was increased on postinfection day (PID) 4 during PRV infection. Finally, intrathecal injection of the CaMKII inhibitor KN-93 attenuated the PRV pain response. These data suggest that CaMKII plays a functional role in pelvic pain due to neurogenic cystitis.
Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Wenbin
W
Yang
Charles N
CN
Rudick
Eneda
E
Hoxha
Stephen A
SA
Allsop
Jordan D
JD
Dimitrakoff
David J
DJ
Klumpp
D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003556:Cystitis / Q000150:complications* / Q000201:enzymology* / Q000821:virology; D004305:Dose-Response Relationship, Drug; D005260:Female; D011558:Herpesvirus 1, Suid; D006930:Hyperalgesia / Q000209:etiology; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D007278:Injections, Spinal; D007527:Isoenzymes / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D046228:Microarray Analysis; D017699:Pelvic Pain / Q000201:enzymology* / Q000209:etiology* / Q000523:psychology; D010766:Phosphorylation; D020671:Posterior Horn Cells / Q000201:enzymology; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D013116:Spinal Cord / Q000378:metabolism; D014158:Transcription, Genetic
D007527:Isoenzymes; D012333:RNA, Messenger; D012313:RNA; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2